The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.
WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its announcement…
Source: Healthcareitnews.com and Read More
Massachusetts health firm reaches $80,000 settlement with HHS following ransomware investigation
The U.S. Department of Health and Human Services (HHS) has fined Elgon Information Systems $80,000 following a ransomware attack in 2023 that saw over 31,000
